Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia
1 clinical trials · Condition
◉ Watch Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia
| Record | Firm | Date |
|---|---|---|
| Blinatumomab Expanded T-cells (BET) in Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia (NCT03823365) | A.O. Ospedale Papa Giovanni XXIII | 2018-12-17 |
Track Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.